Cboe CA - Free Realtime Quote CAD
Eli Lilly and Company (LLY.NE)
29.67
-0.47
(-1.56%)
As of 3:34:14 PM EDT. Market Open.
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 17 | 16 | 28 | 27 |
| Avg. Estimate | 14.37B | 15.36B | 59.57B | 71.42B |
| Low Estimate | 13.96B | 14.49B | 58.31B | 65.07B |
| High Estimate | 14.86B | 16.03B | 62.38B | 79.04B |
| Year Ago Sales | 11.3B | 11.44B | 45.04B | 59.57B |
| Sales Growth (year/est) | 27.15% | 34.27% | 32.25% | 19.89% |
EPS Trend
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| LLY.NE | -- | -- | -- | -- |
| S&P 500 | 13.13% | 2.38% | 7.54% | 14.08% |
Related Tickers
ABBV.NE AbbVie Inc.
27.28
-0.18%
PFE.NE Pfizer Inc.
11.16
-0.62%
MRK.NE Merck & Co., Inc.
18.46
-0.46%
NVON.NE NOVO NORDISK CDR (CAD HEDGED)
8.11
-2.87%
JNJ.NE JOHNSON & JOHNSON CDR (CAD HEDG
20.35
-1.17%
AMGN.NE AMGEN CDR (CAD HEDGED)
22.70
+0.84%
NOVA.SG Novo Nordisk A/S
66.40
-4.18%
MIRA MIRA Pharmaceuticals, Inc.
1.2400
+2.48%
MDCX Medicus Pharma Ltd.
2.7050
+4.04%
NOVN.SW Novartis AG
96.37
-0.81%